Casdatifan (AB521) is a novel and potent allosteric small molecule inhibitor of protumourigenic HIF‐2α dependent transcription.

Saved in:
Bibliographic Details
Title: Casdatifan (AB521) is a novel and potent allosteric small molecule inhibitor of protumourigenic HIF‐2α dependent transcription.
Authors: Schweickert, Patrick G.1 (AUTHOR), Piovesan, Dana1 (AUTHOR), Mitchell, Casey G.1 (AUTHOR), Zepeda‐Carranza, Bryan1 (AUTHOR), Zhu, Wandi S.1 (AUTHOR), Lopez Espinoza, Alejandra Y.1 (AUTHOR), Rocha, Lauren1 (AUTHOR), Singh, Jaskirat1 (AUTHOR), Malgapo, Martin Ian P.1 (AUTHOR), Meleza, Cesar1 (AUTHOR), Northington, Kyle R.1 (AUTHOR), Ray, Rebecca D.1 (AUTHOR), Zhao, Xiaoning1 (AUTHOR), Lawson, Kenneth V.1 (AUTHOR), Walters, Matthew J.1 (AUTHOR), Sivick, Kelsey E.1 (AUTHOR) ksivick@arcusbio.com
Source: British Journal of Pharmacology. Sep2025, Vol. 182 Issue 17, p4147-4167. 21p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00071188
DOI:10.1111/bph.70075